
Poor Outcomes of Hospitalized COVID-19 Patients with Type 2 Diabetes and Chronic Kidney Disease
This paper was presented on May 12th at the 30th Annual Meeting of the American Association of Clinical Endocrinology (AACE) at San Diego, by Drs.
This paper was presented on May 12th at the 30th Annual Meeting of the American Association of Clinical Endocrinology (AACE) at San Diego, by Drs.
This paper was presented on May 12th at the 30thAnnual Meeting of the American Association of Clinical Endocrinology (AACE) at San Diego, by Drs. Nissa
This paper was presented on May 12th at the 30th Annual Meeting of the American Association of Clinical Endocrinology (AACE) at San Diego, by Drs
This paper was presented on May 12th at the 30th Annual Meeting of the American Association of Clinical Endocrinology (AACE) at San Diego, by Dr.
One of the central themes of physicians’ professional lives this past year has been the lack of certainty when addressing COVID-19. From a public health
In developing countries, depressive symptoms are common in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D), particularly those in high-risk groups, according
Although a diagnosis of type 1 diabetes (T1D) should not limit a person’s ability to compete at the highest level of sport, considerations must be